ID   SK-RC-13
AC   CVCL_6178
SY   SK RC 13
DR   Cosmic; 737185
DR   Wikidata; Q54954530
RX   PubMed=479762;
RX   PubMed=2386958;
RX   PubMed=27993170;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 42 hours (PubMed=2386958).
CC   Miscellaneous: STR profile from MSKCC antibody and bioresource core facility.
CC   Derived from metastatic site: Brain.
ST   Source(s): MSKCC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D18S51: 16
ST   D19S433: 12,13
ST   D21S11: 30,31.2
ST   D2S1338: 20,25
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 22
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
OI   CVCL_6175 ! SK-RC-10
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 16-12-21; Version: 16
RX   PubMed=479762; DOI=10.1084/jem.150.3.564;
RA   Ueda R., Shiku H., Pfreundschuh M., Takahashi T., Li L.T.C.,
RA   Whitmore W.F. Jr., Oettgen H.F., Old L.J.;
RT   "Cell surface antigens of human renal cancer defined by autologous
RT   typing.";
RL   J. Exp. Med. 150:564-579(1979).
RX   PubMed=2386958;
RA   Ebert T., Bander N.H., Finstad C.L., Ramsawak R.D., Old L.J.;
RT   "Establishment and characterization of human renal cancer and normal
RT   kidney cell lines.";
RL   Cancer Res. 50:5531-5536(1990).
RX   PubMed=27993170; DOI=10.1186/s12943-016-0565-8;
RA   Brodaczewska K.K., Szczylik C., Fiedorowicz M., Porta C.,
RA   Czarnecka A.M.;
RT   "Choosing the right cell line for renal cell cancer research.";
RL   Mol. Cancer 15:83.1-83.15(2016).